デフォルト表紙
市場調査レポート
商品コード
1318716

肺炎球菌検査市場:方法、技術、製品タイプ、エンドユーザー別-2023-2030年の世界予測

Pneumococcal Testing Market by Method, Technology, Product Type, End-User - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

出版日: | 発行: 360iResearch | ページ情報: 英文 190 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.11円
肺炎球菌検査市場:方法、技術、製品タイプ、エンドユーザー別-2023-2030年の世界予測
出版日: 2023年06月12日
発行: 360iResearch
ページ情報: 英文 190 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

肺炎球菌検査の世界市場は、2023年に16億6,028万米ドル、CAGR 8.97%で大きく成長し、2030年には30億3,415万米ドルに達すると予測されています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界の肺炎球菌検査市場を評価するために不可欠です。ビジネス戦略と製品満足度の主要指標を検証することで、ベンダーの包括的な評価を提供し、ユーザーは特定のニーズに基づいた情報をもとに意思決定を行うことができます。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます:フォアフロント(F)、パスファインダー(P)、ニッチ(N)、バイタル(V)です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客基盤、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します:

1.市場の浸透度:主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展:有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化:新製品の上市、未開発地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向:COVID-19、ロシア・ウクライナ紛争、高インフレの累積的な影響を包括的に理解することができます。

5.競合の評価と情報:主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発およびイノベーション:将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします:

1.肺炎球菌検査の世界市場規模および予測は?

2.予測期間中、世界の肺炎球菌検査市場を形成するCOVID-19の阻害要因と影響は?

3.肺炎球菌検査の世界市場において予測期間中に投資すべき製品/セグメント/アプリケーション/分野は?

4.肺炎球菌検査の世界市場における競争戦略は?

5.肺炎球菌検査の世界市場における技術動向と規制の枠組みは?

6.肺炎球菌検査の世界市場における主要ベンダーの市場シェアは?

7.肺炎球菌検査の世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか?

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 早期診断と治療の改善により肺炎球菌検査の採用が増加
      • 肺炎球菌感染症の有病者数の急増
      • ワクチンと薬剤分子の開発のための臨床試験が進行中
    • 抑制要因
      • 肺炎球菌検査メソッドの開発に伴う高コスト
    • 機会
      • POCテストの人気が高まっています
      • 研究開発投資の増加と体外診断(IVD)検査技術の進歩
    • 課題
      • 専門家の不足
  • 市場動向
  • COVID-19の累積的な影響
  • ロシア・ウクライナ紛争の累積的影響
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み
  • 顧客のカスタマイズ

第6章 肺炎球菌検査市場:方法別

  • 免疫診断
  • 分子診断
  • ポイントオブケア検査

第7章 肺炎球菌検査市場:技術別

  • 酵素免疫測定法
  • 免疫蛍光
  • 免疫組織化学
  • 核酸配列に基づく増幅
  • ポリメラーゼ連鎖反応
  • ウェスタンブロット検査

第8章 肺炎球菌検査市場:製品タイプ別

  • アナライザー
  • 消耗品

第9章 肺炎球菌検査市場:エンドユーザー別

  • 外来手術センター
  • 病院とクリニック

第10章 南北アメリカの肺炎球菌検査市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第11章 アジア太平洋地域の肺炎球菌検査市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第12章 欧州・中東・アフリカの肺炎球菌検査市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第13章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析:主要企業別
  • 競合シナリオ分析:主要企業別

第14章 掲載企業一覧

第15章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. PNEUMOCOCCAL TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. PNEUMOCOCCAL TESTING MARKET SIZE, 2022 VS 2030
  • FIGURE 3. PNEUMOCOCCAL TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2022 VS 2030 (%)
  • FIGURE 5. PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2022 VS 2030 (%)
  • FIGURE 6. PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2022 VS 2030 (%)
  • FIGURE 7. PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
  • FIGURE 8. PNEUMOCOCCAL TESTING MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 9. PNEUMOCOCCAL TESTING MARKET DYNAMICS
  • FIGURE 10. PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS PNEUMOCOCCAL TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC PNEUMOCOCCAL TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 18. PNEUMOCOCCAL TESTING MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 19. PNEUMOCOCCAL TESTING MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. PNEUMOCOCCAL TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. PNEUMOCOCCAL TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 5. PNEUMOCOCCAL TESTING MARKET SIZE, BY IMMUNODIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. PNEUMOCOCCAL TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. PNEUMOCOCCAL TESTING MARKET SIZE, BY POINT OF CARE TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 9. PNEUMOCOCCAL TESTING MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. PNEUMOCOCCAL TESTING MARKET SIZE, BY IMMUNOFLUORESCENCE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. PNEUMOCOCCAL TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. PNEUMOCOCCAL TESTING MARKET SIZE, BY NUCLEIC ACID SEQUENCE BASED AMPLIFICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. PNEUMOCOCCAL TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. PNEUMOCOCCAL TESTING MARKET SIZE, BY WESTERN BLOT TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 16. PNEUMOCOCCAL TESTING MARKET SIZE, BY ANALYZERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. PNEUMOCOCCAL TESTING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 19. PNEUMOCOCCAL TESTING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. PNEUMOCOCCAL TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS PNEUMOCOCCAL TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC PNEUMOCOCCAL TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. AUSTRALIA PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. CHINA PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. INDIA PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. INDONESIA PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. JAPAN PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. MALAYSIA PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. PHILIPPINES PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. SINGAPORE PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. SOUTH KOREA PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. TAIWAN PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. THAILAND PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. VIETNAM PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. DENMARK PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 109. EGYPT PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. FINLAND PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. FRANCE PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. GERMANY PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. ISRAEL PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. ITALY PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. NETHERLANDS PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. NIGERIA PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. NORWAY PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. POLAND PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 149. QATAR PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 153. RUSSIA PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 157. SAUDI ARABIA PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 161. SOUTH AFRICA PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 165. SPAIN PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 169. SWEDEN PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 173. SWITZERLAND PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 177. TURKEY PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 181. UNITED ARAB EMIRATES PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED KINGDOM PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 189. PNEUMOCOCCAL TESTING MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 190. PNEUMOCOCCAL TESTING MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 191. PNEUMOCOCCAL TESTING MARKET LICENSE & PRICING
目次
Product Code: MRR-4103B31E099E

The Global Pneumococcal Testing Market is forecasted to grow significantly, with a projected USD 1,660.28 million in 2023 at a CAGR of 8.97% and expected to reach a staggering USD 3,034.15 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Pneumococcal Testing Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Pneumococcal Testing Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Method, market is studied across Immunodiagnostics, Molecular Diagnostic, and Point of Care Testing. The Molecular Diagnostic is projected to witness significant market share during forecast period.

Based on Technology, market is studied across Enzyme Linked Immunosorbent Assay, Immunofluorescence, Immunohistochemistry, Nucleic Acid Sequence Based Amplification, Polymerase Chain Reaction, and Western Blot Test. The Immunohistochemistry is projected to witness significant market share during forecast period.

Based on Product Type, market is studied across Analyzers and Consumables. The Analyzers is projected to witness significant market share during forecast period.

Based on End-User, market is studied across Ambulatory Surgical Centers and Hospitals & Clinics. The Ambulatory Surgical Centers is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.74% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Pneumococcal Testing Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Pneumococcal Testing Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Pneumococcal Testing Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Pneumococcal Testing Market?

4. What is the competitive strategic window for opportunities in the Global Pneumococcal Testing Market?

5. What are the technology trends and regulatory frameworks in the Global Pneumococcal Testing Market?

6. What is the market share of the leading vendors in the Global Pneumococcal Testing Market?

7. What modes and strategic moves are considered suitable for entering the Global Pneumococcal Testing Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Pneumococcal Testing Market, by Method, 2022 vs 2030
  • 4.3. Pneumococcal Testing Market, by Technology, 2022 vs 2030
  • 4.4. Pneumococcal Testing Market, by Product Type, 2022 vs 2030
  • 4.5. Pneumococcal Testing Market, by End-User, 2022 vs 2030
  • 4.6. Pneumococcal Testing Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing adoption of pneumococcal testing with improvement in early diagnosis and treatment
      • 5.1.1.2. Upsurge in the number of prevalence of pneumococcal disease
      • 5.1.1.3. Ongoing clinical trials for development of vaccines and drug molecules
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with the development of pneumococcal testing methods
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising popularity for POC tests
      • 5.1.3.2. Increasing R&D investments and advancements in testing technologies for in-vitro diagnostic (IVD)
    • 5.1.4. Challenges
      • 5.1.4.1. Dearth of professionals
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Pneumococcal Testing Market, by Method

  • 6.1. Introduction
  • 6.2. Immunodiagnostics
  • 6.3. Molecular Diagnostic
  • 6.4. Point of Care Testing

7. Pneumococcal Testing Market, by Technology

  • 7.1. Introduction
  • 7.2. Enzyme Linked Immunosorbent Assay
  • 7.3. Immunofluorescence
  • 7.4. Immunohistochemistry
  • 7.5. Nucleic Acid Sequence Based Amplification
  • 7.6. Polymerase Chain Reaction
  • 7.7. Western Blot Test

8. Pneumococcal Testing Market, by Product Type

  • 8.1. Introduction
  • 8.2. Analyzers
  • 8.3. Consumables

9. Pneumococcal Testing Market, by End-User

  • 9.1. Introduction
  • 9.2. Ambulatory Surgical Centers
  • 9.3. Hospitals & Clinics

10. Americas Pneumococcal Testing Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Pneumococcal Testing Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Pneumococcal Testing Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
  • 13.2. Market Share Analysis, By Key Player
  • 13.3. Competitive Scenario Analysis, By Key Player

14. List of Company Mentioned

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing